Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ionis Pharmaceuticals

41.55
-0.2100-0.50%
Post-market: 41.550.00000.00%16:23 EDT
Volume:1.42M
Turnover:59.25M
Market Cap:6.61B
PE:-13.86
High:42.58
Open:41.97
Low:41.49
Close:41.76
Loading ...

New Positive Donidalorsen Data to Be Presented at Aaaai/Wao Joint Congress Highlight Sustained Hae Attack Rate Reduction and Disease Control

THOMSON REUTERS
·
20 Feb

Ionis Pharmaceuticals Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
20 Feb

Ionis Pharmaceuticals Price Target Maintained With a $60.00/Share by Needham

Dow Jones
·
20 Feb

Barclays Remains a Hold on Ionis Pharmaceuticals (IONS)

TIPRANKS
·
20 Feb

Q4 2024 Ionis Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents
·
20 Feb

Ionis Pharmaceuticals Inc (IONS) Q4 2024 Earnings Call Highlights: Surpassing Revenue ...

GuruFocus.com
·
20 Feb

Optimistic Buy Rating for Ionis Pharmaceuticals Driven by Promising Financial Outlook and Strategic Advancements

TIPRANKS
·
20 Feb

Ionis Pharmaceuticals price target lowered to $38 from $45 at Stifel

TIPRANKS
·
20 Feb

Ionis Pharmaceuticals Q4 Revenue Growth Exceeds Guidance, Forecasts Over $600 Million In 2025 Sales

Benzinga
·
20 Feb

Ionis Pharmaceuticals trading resumes

TIPRANKS
·
19 Feb

Ionis Pharmaceuticals Shares up 1.6% After Q4 Sales Beat

THOMSON REUTERS
·
19 Feb

Ionis Pharmaceuticals trading halted, volatility trading pause

TIPRANKS
·
19 Feb

Stock Track | Ionis Pharmaceuticals Surges 6.42% Pre-Market on Strong Q4 Beat and Bright 2025 Outlook

Stock Track
·
19 Feb

Ionis Pharmaceuticals Shares up 5% Premarket After Q4 Sales Beat

THOMSON REUTERS
·
19 Feb

Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
19 Feb

Ionis Pharmaceuticals Q4 Net Loss Widens, Revenue Falls; 2025 Sales Guidance Set

MT Newswires Live
·
19 Feb

BUZZ-Ionis Pharma rises on better-than-expected quarterly results

Reuters
·
19 Feb

Ionis Pharmaceuticals sees FY25 revenue $600M, consensus $677.05M

TIPRANKS
·
19 Feb

Ionis Pharmaceuticals: Q4 Earnings Snapshot

Associated Press Finance
·
19 Feb

Ionis Pharmaceuticals Forecasts 2025 Revenue Of Over $600M Versus Consensus Of $675.95M

Benzinga
·
19 Feb